Zevra Therapeutics, Inc.ZVRANASDAQ
Loading
Gross Margin Over TimeExpanding
Percentile Rank69
3Y CAGR-4.9%
5Y CAGR-1.4%
Studio
Year-over-Year Change

Gross profit as a percentage of revenue

3Y CAGR
-4.9%/yr
Annual compound
5Y CAGR
-1.4%/yr
Recent deceleration
Percentile
P69
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM84.22%+22.8%
202468.59%-23.2%
202389.28%-8.7%
202297.82%+5.4%
202192.81%+2.9%
202090.18%+17.0%
201977.06%-
20180.00%-
20170.00%-
20160.00%-